Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Monia

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2000
Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthmaJ G Karras, K McGraw, R A McKay, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Ubiquitin fusion augments the yield of cloned gene products in Escherichia coliT R Butt, S Jonnalagadda, B P Monia, et al.
Transplantation|September 6, 2000
Inhibition of C-raf expression by antisense oligonucleotides extends heart allograft survival in ratsS M Stepkowski, X Qu, M E Wang, et al.
Molecular and Cellular Biology|October 1, 1996
Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathwayT W Schulte, M V Blagosklonny, L Romanova, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 1996
Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivoB P Monia, H Sasmor, J F Johnston, et al.
Molecular Pharmacology|July 27, 1999
Selective killing of cancer cells based on loss of heterozygosity and normal variation in the human genome: a new paradigm for anticancer drug therapyJ P Basilion, A R Schievella, E Burns, et al.
The Journal of Biological Chemistry|July 5, 1993
Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expressionB P Monia, E A Lesnik, C Gonzalez, et al.
The Journal of Biological Chemistry|October 15, 1987
Gene synthesis, expression, structures, and functional activities of site-specific mutants of ubiquitinD J Ecker, T R Butt, J Marsh, et al.
Neuroscience|May 31, 2008
Inhibition of spinal cytosolic phospholipase A(2) expression by an antisense oligonucleotide attenuates tissue injury-induced hyperalgesiaD H Kim, B Fitzsimmons, M P Hefferan, et al.
The Journal of Biological Chemistry|May 5, 1989
Increasing gene expression in yeast by fusion to ubiquitinD J Ecker, J M Stadel, T R Butt, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2000
Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthmaJ G Karras, K McGraw, R A McKay, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Ubiquitin fusion augments the yield of cloned gene products in Escherichia coliT R Butt, S Jonnalagadda, B P Monia, et al.
Transplantation|September 6, 2000
Inhibition of C-raf expression by antisense oligonucleotides extends heart allograft survival in ratsS M Stepkowski, X Qu, M E Wang, et al.
Molecular and Cellular Biology|October 1, 1996
Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathwayT W Schulte, M V Blagosklonny, L Romanova, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 1996
Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivoB P Monia, H Sasmor, J F Johnston, et al.
Molecular Pharmacology|July 27, 1999
Selective killing of cancer cells based on loss of heterozygosity and normal variation in the human genome: a new paradigm for anticancer drug therapyJ P Basilion, A R Schievella, E Burns, et al.
The Journal of Biological Chemistry|July 5, 1993
Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expressionB P Monia, E A Lesnik, C Gonzalez, et al.
The Journal of Biological Chemistry|October 15, 1987
Gene synthesis, expression, structures, and functional activities of site-specific mutants of ubiquitinD J Ecker, T R Butt, J Marsh, et al.
Neuroscience|May 31, 2008
Inhibition of spinal cytosolic phospholipase A(2) expression by an antisense oligonucleotide attenuates tissue injury-induced hyperalgesiaD H Kim, B Fitzsimmons, M P Hefferan, et al.
The Journal of Biological Chemistry|May 5, 1989
Increasing gene expression in yeast by fusion to ubiquitinD J Ecker, J M Stadel, T R Butt, et al.
Pageof 8